Find the latest Optometry and Glaucoma news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.
Log in or Sign up for Free to view tailored content for your specialty!
June 17, 2026
1 min read
Save
Bayer acquires Perfuse Therapeutics
Bayer has acquired Perfuse Therapeutics, including the full rights to the PER-001 intravitreal implant, which is in development…
Find the latest Optometry and Therapeutics news articles, videos, podcasts, and meeting coverage from medical experts and key…
Implantation of iStent inject led to significantly lower eye drop burden in patients with glaucoma, according to a study…
Find the latest Primary Care Optometry news articles, videos, podcasts, and meeting coverage from medical experts and key opinion…
Centered around a glaucoma therapy in mid-stage testing, the deal is Bayer’s first drug company acquisition in several years and…
Bayer Completes Acquisition of Perfuse Therapeutics
